The Glioblastoma Multiforme Treatment Market was valued at approximately USD 2.8–2.9 billion in 2023–2024 and is projected to reach USD 5.6–5.7 billion by 2032–2033, with a compound annual growth rate (CAGR) of around 8–9%. Growth is driven by rising GBM incidence, increased adoption of advanced therapies like radiotherapy, immunotherapy, and novel targeted agents, along with expandin... https://www.datamintelligence.com/research-report/glioblastoma-multiforme-market